Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 172,783Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1NOVO NORDISK A/S

02 18Novo Nordisk A/S

03 1Novo Nordisk A/S (2)

04 6Novo Nordisk Pharma Ag

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

degludec

Brand Name : Tresiba

Dosage Form : Insulin Degludec 300Iu 3Ml 5 Units Parenteral Use

Dosage Strength : FLEXTOUCH SC 5 pens preriemp 3 ml 100 IU/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

02

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

degludec

Brand Name : Tresiba

Dosage Form : Injection fluid, resolution

Dosage Strength : 100 E/ml

Packaging : Finish filled pen, flex touch

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

03

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

degludec

Brand Name : Tresiba

Dosage Form : Injection fluid, resolution

Dosage Strength : 100 E/ml

Packaging : Sylinderampulle

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

04

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

degludec

Brand Name : Tresiba

Dosage Form : Injection fluid, resolution

Dosage Strength : 200 E/ml

Packaging : Finish filled pen, flex touch

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

05

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

degludec

Brand Name : Xultophy

Dosage Form : Injection fluid, resolution in the finished filled pen

Dosage Strength : 100 E/ml/3.6 mg/ml

Packaging : Finish filled pen

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

06

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Insulin Degludec

Brand Name : Tresiba Penfill

Dosage Form : Solution For Injection

Dosage Strength :

Packaging :

Approval Date : 12/03/2013

Application Number : 62562

Regulatory Info : Allowed

Registration Country : Switzerland

blank

07

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Insulin Degludec

Brand Name : Tresiba FlexTouch Eml

Dosage Form : Solution For Injection

Dosage Strength : 100E/ml

Packaging :

Approval Date : 12/03/2013

Application Number : 62563

Regulatory Info : Allowed

Registration Country : Switzerland

blank

08

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Insulin Degludec

Brand Name : Tresiba FlexTouch Eml

Dosage Form : Solution For Injection

Dosage Strength : 200E/ml

Packaging :

Approval Date : 12/03/2013

Application Number : 62563

Regulatory Info : Allowed

Registration Country : Switzerland

blank

09

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Insulin Degludec; Insulin Aspart

Brand Name : Ryzodeg Penfill

Dosage Form : Solution For Injection

Dosage Strength : 420nmol/ml;180nmol/ml

Packaging :

Approval Date : 12/09/2013

Application Number : 62627

Regulatory Info : Allowed

Registration Country : Switzerland

blank

10

OTS 2025
Not Confirmed
arrow
arrow
OTS 2025
Not Confirmed

Insulin Degludec; Insulin Aspart

Brand Name : Ryzodeg FlexTouch

Dosage Form : Solution For Injection

Dosage Strength : 420nmol/ml;180nmol/ml

Packaging :

Approval Date : 12/09/2013

Application Number : 62648

Regulatory Info : Allowed

Registration Country : Switzerland

blank